Les Sources
Pour rédiger ses fiches et dossiers ou renseigner sa base de données sur les composants des produits alimentaires, cosmétiques et chimiques, l?équipe d?Eassafe.com se base sur de nombreuses publications scientifiques et/ou institutionnelles dont des revues scientifiques (Alim?inter, Allergy, Annals of Allergy Asthma and Immunology, Clinical and Experimental Allergy, Contact Dermatitis, Journal of Allergy and Clinical Immunology, Revue Française d?Allergologie) et des sites institutionnels (Afssa, Codex alimentarius, Journal Officiel de l?Union Européenne, Réseau d'allergovigilance)
- 76. Cistero-Bahima AM, San Miguel-Moncin M, Alonso R et al. Allergic lipstick cheilitis due to Propyl Gallates. J Allergy Clin Immunol 2005; 115 (2 suppl.): S31.
- 77. Botzi C, Wantke F, Hemmer W et al. Contact dermatitis to jojoba oil and myristal lactate/maleated soybean oil. J Allergy Clin Immunol 1996; 97: 372.
- 78. Funk JO, Maibach HI. PG dermatitis: re-evaluation of an old problem. Contact Dermatitis 1994; 31: 236-241.
- 79. Brande I, Boujnah-Khouadja, Foussereau J. Allergy to castor oil. Contact Dermatitis 1983; 9: 121.
- 80. Sais I. Contact dermatitis to castor oil in a lipstick. Contact Dermatitis 1983; 9: 75.
- 81. Fischer AA. Allergic cheilitis due to castor oil in lipsticks. Cutis 1991; 87: 389.
- 82. Di Berardino L, Della Torre F. Side effects to castor oil. Allergy 2003; 58: 826.
- 83. Reider N, Komericki P, Hausen BM et al. The seamy side of natural medicines: contact sensitization to arnica (Arnica Montana L.) and marigold (Calendula officinalis L.). Contact Dermatis 2001; 45: 269-272.
- 84. Paulsen E. Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis 2002; 47: 189-198.
- 85. Paulsen E, Christensen LP, Andersen KE. Cosmetics and herbal remedies with Compositae plant extracts – are they tolerated by Compositae-allergic patients? Contact Dermatitis 2008; 58: 15-23.
- 86. Granlung H. Contact allergy to witch hazel. Contact Dermatitis 1994; 31: 195.
- 87. Mitchell DM, Back MH. Contact allergy to benzyl alcohol in a cutting oil reodorant. Contact Dermatitis 1988 ; 18 : 301-302.
- 88. Oei HD. Eyelid dermatitis due to contact allergy to cocamido-propyl betaine. J Allergy Clin Immunol
- 89. Groot AC, Van der Walle HB, Weyland JW. Contact allergy to cocamidopropylbetaine. Contact Dermatitis 1995; 33: 419-422.
- 90. Jacob SE, Amini S. Cocamidopropylbetaine. Dermatitis 2008, 19: 157-160.
- 91. Knopp E, Watsky K. Contact allergy to 3-(dimethylamino)propylamine. Dermatitis 2008; 19: 328-333.
- 92. Moreau L, Sasseville D. Allergic contact dermatitis from cocamidopropylbetaine, cocamidoamine, 3-(dimethylamino)propylamine, and oleamidopropyl dimethylamine : co-reactions or cross reactions ? Dermatitis 2004; 15: 146-149.
- 93. Shaffer KK, Jaimes JP, Hordinsky MK et al. Allergenicity and cross-reactivity of coconut oil derivatives: a double-blind randomized controlled pilot study. Dermatitis 2006; 17: 71-76.
- 94. Bryld LE, Agner T, Menné T. Allergic contact dermatitis from 3-iodo-2-propynyl-butylcarbamate (IPBC) - an update. Contact Dermatitis 2001; 44: 276-278.
- 95. Downs AM, Sansom JE. Colophony allergy: a review. Contact Dermatitis 1999; 41: 305-310.
- 96. Statham BN, Smith EV, Bodger OG, et al. Concomitant contact allergy to methyl-chloroisothiazolinone/methylisothiazolinone and formaldehyde-releasing preservatives. Contact Dermatitis 2010; 62: 56-57.
- 97. Lundov MD, Moesby L, Zachariae C, Johansen JD. Contamination versus preservation of cosmetics: a review of legislation, usage, infections, and contact allergy. Contact Dermatitis 2009; 60: 70-78.
- 98. Alexander BR. An assessment of the comparative sensitization potential of some common isothiazolinones. Contact Dermatitis 2002; 46: 191-196.
- 99. Niinimäki A, Niinimäki M, Mäkinen-Kiljunen S, Hannuksela M. Contact urticaria from protein hydrolysates in hair conditioners. Allergy 1998, 53: 1078-1082.
- 100. Goossens A, Lepoittevin JP. Allergie de contact aux cosmétiques et aux composants de parfums: aspects cliniques, chimiques et diagnostiques nouveaux. Rev Fr Allergol Immunol Clin 2003; 43: 294-300.